Cargando…
Radiation and Dual Checkpoint Blockade Activates Non-Redundant Immune Mechanisms in Cancer
Immune checkpoint inhibitors(1) result in impressive clinical responses(2–5) but optimal results will require combination with each other(6) and other therapies. This raises fundamental questions about mechanisms of non-redundancy and resistance. Here, we report major tumor regressions in a subset o...
Autores principales: | Victor, Christina Twyman-Saint, Rech, Andrew J., Maity, Amit, Rengan, Ramesh, Pauken, Kristen E., Stelekati, Erietta, Benci, Joseph L., Xu, Bihui, Dada, Hannah, Odorizzi, Pamela M., Herati, Ramin S., Mansfield, Kathleen D., Patsch, Dana, Amaravadi, Ravi K., Schuchter, Lynn M., Ishwaran, Hemant, Mick, Rosemarie, Pryma, Daniel A., Xu, Xiaowei, Feldman, Michael D., Gangadhar, Tara C., Hahn, Stephen M., Wherry, E. John, Vonderheide, Robert H., Minn, Andy J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401634/ https://www.ncbi.nlm.nih.gov/pubmed/25754329 http://dx.doi.org/10.1038/nature14292 |
Ejemplares similares
-
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomes
por: Maity, Amit, et al.
Publicado: (2021) -
Stereotactic body radiation therapy and CTLA-4 blockade as a novel therapy for advanced melanoma
por: Twyman, Christina, et al.
Publicado: (2013) -
Long-term outcomes of a phase I study of agonist CD40 antibody and CTLA-4 blockade in patients with metastatic melanoma
por: Bajor, David L., et al.
Publicado: (2018) -
Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8(+) T cells
por: Odorizzi, Pamela M., et al.
Publicado: (2015) -
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
por: Maity, Amit, et al.
Publicado: (2018)